Skip to Content

Epizyme

EPZM

Buy $EPZM at eToro
Rank 4671
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 400 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE, MA, US

Epizyme - Key figures

Market cap 247.5 Million
Revenue 53.01 Million
Profit 18.57 Million
P/E Ratio No information
P/s Ratio 4.669
Buy $EPZM at eToro

Epizyme - Description

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and markets new epigenetic drugs for patients with cancer and other diseases in the United States.

The company is headquartered in Cambridge, Massachusetts.